Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.

Abstract

Methamphetamine addiction causes serious public health problems worldwide. However, there is no effective medication licensed for methamphetamine addiction. The endogenous opioid system is considered to be a common substrate in drug addiction due to its regulation of dopamine release. In recent clinical trials, (-)-naltrexone, an opioid receptors and Toll-like receptor 4 antagonist, has exhibited encouraging findings for treating methamphetamine addiction; however, the understanding of its pharmacological mechanisms remains insufficient. By using mice models of behavioral sensitization and conditioned place preference (CPP), the present study was performed to investigate the effects of naltrexone on the methamphetamine-associated properties of incentive salience and reward-related memory, the two crucial factors for the development of addictive process and relapse. We found that naltrexone reduced single methamphetamine-induced hyperlocomotion in mice. In the paradigm of methamphetamine-induced behavioral sensitization paired with contextual cues in mice, naltrexone suppressed the development and expression of locomotor sensitization, suggesting the decrease in incentive salience to methamphetamine and context. In the methamphetamine-induced CPP paradigm in mice, naltrexone attenuated both the expression and methamphetamine-priming reinstatement of CPP response, suggesting the impairment of either contextual cue- or drug-induced retrieval of methamphetamine-associated memory. After the establishment of methamphetamine-induced CPP in mice, naltrexone treatment during the extinction training produced conditioned place adverse response, suggesting that naltrexone facilitated negative affection-associated extinction learning. Taken together, these findings demonstrate that naltrexone could intervene in the properties of incentive salience and reward-related memory in methamphetamine addiction, which may contribute to its therapeutic effects on methamphetamine addicts in clinical studies.

• Authors: Zhi-Yuan Wang, Liang-Kun Guo, Xiao Han, Rui Song, Guo-Ming Dong, Chun-Ming Ma, Ning Wu, Jin Li
• Journal: Behavioural brain research (Behav Brain Res) Vol. 399 Pg. 112971 (02 05 2021) ISSN: 1872-7549 [Electronic] Netherlands
• PMID: 33075396 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020. Published by Elsevier B.V.

Chemical References

• Central Nervous System Stimulants
• Narcotic Antagonists
• Methamphetamine
• Naltrexone

Topics

• Amphetamine-Related Disorders (drug therapy)
• Animals
• Behavior, Animal (drug effects)
• Central Nervous System Sensitization (drug effects)
• Central Nervous System Stimulants (administration & dosage, pharmacology)
• Conditioning, Classical (drug effects)
• Disease Models, Animal
• Extinction, Psychological (drug effects)
• Male
• Mental Recall (drug effects)
• Methamphetamine (administration & dosage, pharmacology)
• Mice
• Motivation (drug effects)
• Naltrexone (administration & dosage, pharmacology)
• Narcotic Antagonists (administration & dosage, pharmacology)